Key result
18FDG PET/CT outperforms conventional methods for tracking inflammation and guiding inflammatory heart disease therapy.
Why the study?
Diagnosis of endocarditis, myocarditis, and pericarditis remains challenging due to subtle clinical manifestations and requires advanced imaging to avoid life-threatening consequences.
Does 18FDG PET/CT improve the assessment and management of inflammatory heart diseases compared to conventional methods?
Does 18FDG PET/CT improve the assessment and management of inflammatory heart diseases compared to conventional methods?
18FDG PET/CT is a valuable advanced multimodal imaging tool for the early detection, quantification, and management of inflammatory heart diseases such as endocarditis, myocarditis, and pericarditis.
May aid diagnosis of cardiac inflammatory syndromes when suspicion is high; extends imaging literature but leaves open prospective validation.
Endocarditis, myocarditis and pericarditis are a heterogeneous group of phenotypic syndromes where the culprit area of inflammation is the heart. Inflammation may be determined by an infective agent, toxins, drugs or an activated immune system. Clinical manifestations can be subtle and diagnosis remains a challenge for cardiologists, requiring high level of suspicion and advanced multimodal cardiac imaging to avoid life-threatening consequences. The purpose of this review is to report the recent advances of PET/CT imaging with 18FDG in helping the management of patients affected by inflammatory heart disease. Two independent reviewers searched in PubMed articles published before or in June 2019 and final decisions on the inclusion of references were done in consensus with a third reviewer. At the end of the selection process 23/206 articles on "cardiac inflammation"; 26/235 articles on "endocarditis", "prosthetic heart valve", "pacemaker", "implantable cardiac device"; 7/103 articles on "myocarditis"; 13/330 articles on sarcoidosis" and 2/19 articles on "pericarditis" were included. Compared with the conventional methods, molecular imaging has the advantage to non-invasively and directly trace the inflammatory process, and to identify earlier the presence and the extent of intra-cardiac and extra-cardiac involvement, to enable quantification of disease activity, guide therapeutic interventions, and monitor treatment success.
No takes yet. Share an insight, caveat, or question.
Giorgetti et al. (2020) conducted a review in Endocarditis, myocarditis and pericarditis. 18FDG PET/CT imaging vs. Conventional methods was evaluated. 18FDG PET/CT imaging offers advantages over conventional methods by non-invasively tracing inflammation, identifying early involvement, and guiding treatment in inflammatory heart diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: